Sapanisertib is an Orally Active mTOR1/2 Inhibitor for Prostate Cancer Research
mTOR, the mammalian target of rapamycin, is a conserved serine/threonine kinase. mTOR often serves as a catalytic subunit and consists of two protein complexes: mTOR complex 1 and mTOR complex…